Exelixis
Christopher J. Senner is the EVP and CFO at Exelixis. Christopher has over 25 years of experience in the pharmaceutical and biotech industry. Prior to joining Exelixis, they served as the VP of Corporate Finance at Gilead Sciences, where they were responsible for financial planning and analysis, controllership, tax, and treasury. Before that, they were the VP of Finance and CFO US Region at Wyeth Pharmaceuticals.
Their manager is Michael M. Morrissey, President & CEO. Some of their coworkers include Peter Lamb - EVP, Scientific Strategy & Chief Scientific Officer, Jeffrey J. Hessekiel - EVP, General Counsel & Secretary, and Vicki L. Goodman - EVP, Product Development & Medical Affairs, & Chief Medical Officer.
This person is not in any offices
Exelixis
15 followers
Exelixis strives to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future.